Gilead Sciences AktieWKN: 885823 / ISIN: US3755581036
Symbol: GILD

68,61EUR
-0,26EUR
-0,37%
18:00:29
80,91USD
-0,68USD
-0,83%
19:52:02
KAUFEN
VERKAUFEN

Gilead Sciences News

13:31 Uhr
Celgene Could Be the Best CAR-T Stock to Buy, Not Gilead Sciences (MotleyFool)
13:31 Uhr
Celgene Could Be the Best CAR-T Stock to Buy, Not Gilead Sciences (FOX Business)
01:31 Uhr
Gilead Slaps Mega-Price on Its Newly Approved CAR-T (MotleyFool)
19.10.17
Gilead: A New Cancer Drug! Great…But You Still Overpaid for Kite (The Wall Street Journal)
19.10.17
Gilead: A New Cancer Drug! Great…But You Still Overpaid for Kite (EN, Barrons)
19.10.17
Morning Movers: Gilead Gains, Nike Drops, Philip Morris Tumbles (The Wall Street Journal)
19.10.17
Morning Movers: Gilead Gains, Nike Drops, Philip Morris Tumbles (EN, Barrons)
19.10.17
Gilead Sciences shares bolstered in New York after FDA approval validates Kite Pharma merger (Proactiveinvestors)
19.10.17
Gilead Sciences shares bolstered after FDA approval validates Kite Pharma merger (Proactiveinvestors)
19.10.17
Verizon Communications, Gilead Sciences, Alcoa Corp, PayPal Holdings Inc - PRE-MARKET (Proactiveinvestors)
19.10.17
Verizon Communications, Gilead Sciences, Alcoa Corp, PayPal Holdings - PRE-MARKET (Proactiveinvestors)
19.10.17
Maydorns Meinung: SAP, BYD, Tesla, JinkoSolar, Gilead, Medigene, Millennial Lithium (Der Aktionär)
19.10.17
BB-Biotech-Beteiligung Gilead mit Paukenschlag: Aktie kräftig im Plus (Der Aktionär)
19.10.17
FDA approves Gilead cancer gene therapy; price set at $373,000 (FOX Business)
19.10.17
The Wall Street Journal: Gilead shares rise after FDA approves cell-therapy drug Yescarta (MarketWatch)
19.10.17
Gilead Gets FDA Approval for New Cancer Therapy (The Wall Street Journal)
28.09.17
Why Gilead Sciences, Pier 1 Imports, and PetMed Express Slumped Today (MotleyFool)
28.09.17
Gilead Sciences: 'We Don't Think That His Departure Is a Red Herring' (The Wall Street Journal)
28.09.17
Gilead Sciences: ‘We Don’t Think That His Departure Is a Red Herring’ (EN, Barrons)
28.09.17
Gilead shares decline nearly 5% after COO says he will retire (Market Watch)
28.09.17
Vertex Pharmaceuticals: The Gilead Sciences of Cystic Fibrosis? (MotleyFool)
26.09.17
Gilead Sciences: New Market, Same Problem? (The Wall Street Journal)
26.09.17
Gilead Sciences: New Market, Same Problem? (EN, Barrons)
22.09.17
Why Is Cash-Rich Gilead Sciences, Inc. Borrowing $3 Billion? (MotleyFool)
19.09.17
Gilead Sciences' Kite Pharma Deal Has Already Paid for Itself -- for Investors (MotleyFool)
18.09.17
Gilead Sciences: Is The Kite Deal Too Little, Too Late? (The Wall Street Journal)
18.09.17
Gilead Sciences: Is The Kite Deal Too Little, Too Late? (EN, Barrons)
15.09.17
After Gilead Sciences, More Biotech M&A? (EN, Barrons)
15.09.17
3 Reasons Why Gilead Sciences Stock Is a Buy Now (MotleyFool)
13.09.17
Gilead Sciences, Inc.'s Best Investment of 2017 (Hint: It Wasn't Kite Pharmaceuticals) (MotleyFool)
13.09.17
Gilead: Too Early for Kite Credit? (The Wall Street Journal)
13.09.17
Gilead: Too Early for Kite Credit? (EN, Barrons)
11.09.17
5 Tough Questions for Gilead Sciences About the Kite Pharma Acquisition (MotleyFool)
07.09.17
Are You Buying Gilead Sciences, Inc. for the Wrong Reason? (MotleyFool)
07.09.17
5 Things Gilead Sciences' Management Just Said That You'll Want to Know (MotleyFool)
Euro am Sonntag-Aktien-Check
Gilead Sciences: Mit neuem Zukunftsprojekt
Zwölf Milliarden Dollar zahlt der US-Pharmakonzern für die Biotechfirma Kite Pharma.
05.09.17
Gilead Sciences Couldn't Have Timed its Splash Into CAR-T Better (MotleyFool)
03.09.17
Better Buy: Gilead Sciences, Inc. vs. Johnson & Johnson (MotleyFool)
03.09.17
Why Gilead Sciences Shares Soared 10.6% in August (MotleyFool)
02.09.17
3 Reasons Gilead Sciences Jumped to Buy Kite Pharma (MotleyFool)
Seite: 123456789...24

Gilead Sciences News

Gilead Sciences News: auf dieser Seite finden Sie alle Gilead Sciences News und Nachrichten zur Gilead Sciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Gilead Sciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Gilead Sciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.

Online Brokerage über finanzen.net

Das Beste aus zwei Welten: Handeln Sie für nur 5 Euro Orderprovision* pro Trade unmittelbar aus der Informationswelt von finanzen.net!
Zur klassischen Ansicht wechseln
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Daimler AG710000
Deutsche Bank AG514000
BYD Co. Ltd.A0M4W9
Volkswagen (VW) AG Vz.766403
EVOTEC AG566480
GeelyA0CACX
Apple Inc.865985
CommerzbankCBK100
Varta AGA0TGJ5
Nordex AGA0D655
Bitcoin Group SEA1TNV9
E.ON SEENAG99
Infineon AG623100
Amazon906866
Allianz840400